Rita Karachun
Chief Executive Officer at IMMUNE DESIGN CORP
Net worth: 6 M $ as of 2024-04-29
Profile
Rita A.
Karachun is currently the Chief Executive Officer & Director at Immune Design Corp., Prometheus Biosciences, Inc., ArQule, Inc., Acceleron Pharma, Inc., Harrisvaccines LLC, GlycoFi, Inc., and Imago BioSciences, Inc. She previously worked as a Director at Organon & Co., Senior Vice President-Finance & Global Controller at Merck & Co., Inc., and President at Inspire Pharmaceuticals, Inc.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
MERCK & CO., INC.
0.00% | 2023-05-03 | 45,709 ( 0.00% ) | 6 M $ | 2024-04-29 |
Rita Karachun active positions
Companies | Position | Start |
---|---|---|
IMMUNE DESIGN CORP | Chief Executive Officer | - |
ARQULE, INC. | President | 2020-01-15 |
ACCELERON PHARMA INC. | President | 2021-11-18 |
IMAGO BIOSCIENCES, INC. | President | - |
PROMETHEUS BIOSCIENCES, INC. | Chief Executive Officer | 2023-06-15 |
GlycoFi, Inc.
GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | President | - |
Harrisvaccines LLC
Harrisvaccines LLC BiotechnologyHealth Technology Harrisvaccines LLC develops vaccine technology for the treatment and prevention of infectious diseases in swine and cattle. Its pipeline products comprise vaccines for viral diseases. The company was founded by Hank Harris in 2005 and is headquartered in Ames, IA. | President | - |
Former positions of Rita Karachun
Companies | Position | End |
---|---|---|
MERCK & CO., INC. | Comptroller/Controller/Auditor | 2023-12-03 |
ORGANON & CO. | Director/Board Member | 2021-06-01 |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
ORGANON & CO. | Health Technology |
Private companies | 8 |
---|---|
GlycoFi, Inc.
GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Health Technology |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Harrisvaccines LLC
Harrisvaccines LLC BiotechnologyHealth Technology Harrisvaccines LLC develops vaccine technology for the treatment and prevention of infectious diseases in swine and cattle. Its pipeline products comprise vaccines for viral diseases. The company was founded by Hank Harris in 2005 and is headquartered in Ames, IA. | Health Technology |
Imago BioSciences, Inc.
Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
- Stock Market
- Insiders
- Rita Karachun